BioRestorative Therapies earnings

Next report

No new earnings release has been filed with the SEC for longer than its usual quarter. The company has not announced a date.

Who else reports that week: the earnings calendar.

Last report: Nov 12, 2025, 21:11 ET (after the close). The filing on SEC EDGAR ↗

Across the last 1 report we hold closes for, the first close moved a median 9.42% either way. Up 0 of 1.

Moves are only shown for reports where we hold closing prices.

1. Nov 12, 202521:11 ET · after the close8-K ↗−9.42%1DRevenue $11.80K−94.9% y/yEPS −$0.33quarter to Sep 30, 2025
2. Before Sep 2, 2025 we don't hold closing prices, so these reports show the date and what was filed, without a move.
3. Aug 12, 202520:16 ET · after the close8-K ↗Revenue $303.3K+240.4% y/yEPS −$0.30quarter to Jun 30, 2025
4. May 14, 202520:11 ET · after the close8-K ↗Revenue $25.00K−28.6% y/yEPS −$0.64quarter to Mar 31, 2025
5. Mar 27, 202520:11 ET · after the close8-K ↗Revenue $43.30K+124.4% y/yquarter to Dec 31, 2024
6. Nov 13, 202421:07 ET · after the close8-K ↗Revenue $233.6K+660.9% y/yEPS −$0.13quarter to Sep 30, 2024
7. Aug 13, 202420:11 ET · after the close8-K ↗Revenue $89.10K+38.1% y/yEPS −$0.50quarter to Jun 30, 2024

Move = the first close after the release against the close before it. A release after 4pm ET is priced by the next session; one before 9:30am ET by that day’s. Times are when the SEC accepted the 8-K (Item 2.02), which follows the press release by minutes. Closes held from Sep 2, 2025; “no price data” means we don't hold the closes for that report. 1 other Item 2.02 filing, filed weeks ahead of a report (a delivery or preliminary update), is not counted as a report. Prior-session closes only; not a forecast, not advice.